Related news:
Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup - Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup - Pharma is hopeful about Trump's second term -- here's what to expect for drugmakers - Pharma, med-tech seek sops to boost research - Trump's Ozempic tariffs, Zepbound on Medicare, and rising drug prices: Pharma news roundup - New drugs mean higher prices -- and a big year for Big Pharma - Pharma and agritech groups push against biodiversity levy at UN summit - Off-brand Ozempic, Roche stock woes, and Eli Lilly's weekly insulin: Pharma news round up - 'Exciting idea': Fund manager loves this pharma stock -- and analysts see more upside ahead
MS PHARMA
Bookmark
ShareMS PHARMA is a company. It is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- sector: Health Care
- industry: Pharmaceuticals
Classified as: organization
Business
MS PHARMA is one of the companies in Pharmaceuticals, companies in Health Care and 3,466,499 companies in our database.
- Employees:
Try Pro to see estimates
- Revenues:
Try Pro to see estimates
Stocks from MS PHARMA:
Talking Points:
- Loading ...
- Improve our communities' quality of life by increasing the access to high quality and affordable products. | MS Pharma is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. With the introduction of a new senior leadership team lead by CEO Kalle Känd, a Corporate ...
Learn more about talking points
